blackboard1965 /
26 August 2016Asia

Mylan biosimilar application moves forward

The European Medicines Agency has accepted pharmaceutical company Mylan’s request to review its application for a biosimilar of Herceptin (trastuzumab).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at